The complement system is a major component of innate immunity and acts in parallel or in concert with the immune system. Complement activation provides an effective host defense mechanism against foreign organisms by generating effector molecules, which are involved in cell death and immune/inflammatory responses. Because of its potent inflammatory and destructive capabilities several complement regulatory proteins strictly control complement activation. These proteins provide a recognition system to distinguish self from non-self, thus limiting damage to host tissue. The anterior chamber of the eye is an immune privileged site and control of complement activation at this site may be important in preserving vision. Our results demonstrate that four complement regulatory proteins namely Crry, CD59, MCP and DAF are expressed within the normal rat eye and their expression is upregulated during experimental autoimmune anterior uveitis (EAAU). Furthermore, normal human intraocular fluid also contains a yet unidentified 55 kDa complement inhibitory protein. These results provide evidence that a complement regulatory system exists in the eye to protect ocular tissue from destruction by complement activating events. Identification and characterization of complement regulatory proteins in the eye would be a major advance toward the understanding of intraocular inflammation and protection of the eye. These studies should provide insights into the relevance of complement regulatory proteins in uveitis and may be therapeutically useful for suppressing intraocular inflammatory responses and tissue damage.
The specific aims of this proposal are: 1. Role of complement regulatory proteins in experimental autoimmnune anterior uveitis (EAAU), 2. Suppression of EAAU by soluble complement regulatory protein(s), and 3. Characterization of 55 kDa complement inhibitor present in normal human aqueous humor/vitreous.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY013335-04
Application #
6781057
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Shen, Grace L
Project Start
2001-08-01
Project End
2006-01-04
Budget Start
2004-08-01
Budget End
2006-01-04
Support Year
4
Fiscal Year
2004
Total Cost
$189,495
Indirect Cost
Name
University of Louisville
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Davis, Stephen J; Lyzogubov, Valeriy V; Tytarenko, Ruslana G et al. (2012) The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration. Retina 32:1171-80
Lyzogubov, Valeriy V; Tytarenko, Ruslana G; Thotakura, Sushma et al. (2009) Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II. Cell Biol Int 33:765-71
Jha, Purushottam; Bora, Puran S; Bora, Nalini S (2007) The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 44:3901-8
Jha, Purushottam; Matta, Bharati; Lyzogubov, Valeriy et al. (2007) Crucial role of apoptosis in the resolution of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 48:5091-100
Bora, Nalini S; Kaliappan, Sankaranarayanan; Jha, Purushottam et al. (2007) CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol 178:1783-90
Bora, Nalini S; Kaliappan, Sankaranarayanan; Jha, Purushottam et al. (2006) Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol 177:1872-8
Jha, Purushottam; Sohn, Jeong-Hyeon; Xu, Qin et al. (2006) The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 47:1030-8
Jha, Purushottam; Sohn, Jeong-Hyeon; Xu, Qin et al. (2006) Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol 176:7221-31
Bora, Puran S; Sohn, Jeong-Hyeon; Cruz, Jose M C et al. (2005) Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 174:491-7
Bora, Nalini S; Sohn, Jeong-Hyeon; Bora, Puran S et al. (2005) Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU). Ocul Immunol Inflamm 13:183-9

Showing the most recent 10 out of 13 publications